Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

RTTNews | 720 dagar sedan
Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

(RTTNews) - Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

The review, which resulted in a Complete Response Letter, was based on the CodeBreaK 200 trial results for the treatment of adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC).

The FDA also issued a new postmarketing requirement (PMR) for an additional confirmatory study to support full approval that will be completed no later than February 2028.

In addition, the FDA concluded that the dose comparison PMR issued at the time of LUMAKRAS accelerated approval, to compare the safety and efficacy of LUMAKRAS 960 mg daily dose versus a lower daily dose, has been fulfilled.

The company said LUMAKRAS at 960 mg once-daily will remain the dose for patients with KRAS G12C-mutated NSCLC under accelerated approval.

read more
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...
RTTNews | 564 dagar sedan
Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
RTTNews | 1210 dagar sedan
Japan Manufacturing PMI Data On Tap For Tuesday

Japan Manufacturing PMI Data On Tap For Tuesday

Japan will on Tuesday see December results for the manufacturing, services and composite PMIs from Jibun Bank, highlighting a light day for Asia-Pacific economic activity.
RTTNews | 1h 32minuter sedan
Eurozone Industrial Production Growth Strongest In 5 Months

Eurozone Industrial Production Growth Strongest In 5 Months

Euro area industrial production increased at the fastest pace in five months in October led by robust output growth in the energy sector and non-durable goods manufacturing, preliminary data from the statistical office Eurostat showed on Monday.
RTTNews | 6h 17minuter sedan
U.S. Homebuilder Confidence Inches Up In Line With Estimates In December

U.S. Homebuilder Confidence Inches Up In Line With Estimates In December

The National Association of Home Builders released a report on Monday showing a modest improvement by U.S. homebuilder confidence in the month of December. The report said the NAHB/Wells Fargo Housing Market Index crept up to 39 in December after inching up to 38 in November. The uptick, which matched economist estimates, lifted the index to its highest level since hitting 40 in April.
RTTNews | 8h 30minuter sedan
New York Manufacturing Index Unexpectedly Turns Negative In December

New York Manufacturing Index Unexpectedly Turns Negative In December

A report released by the Federal Reserve Bank of New York on Monday showed an unexpected downturn by regional manufacturing activity in the month of December. The New York Fed said its general business conditions index plunged to a negative 3.9 in December from a positive 18.7 in November, with a negative reading indicating contraction. Economists had expected the index to fall to a positive 10.6
RTTNews | 9h 27minuter sedan